# Contact Peptide Research Protocols — Editorial Desk

> Reach the Peptide Research Protocols editorial desk regarding citations, corrections or research-related correspondence about the Growth Hormone Axis peptide digest.

Correspondence on citations, corrections, and research-related enquiries — the things a reference digest most wants to hear about.

## Editorial correspondence

Peptide Research Protocols welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about tesamorelin, MOTS-c or CJC-1295 that should be incorporated into the [references page](/references). Corrections that improve the accuracy of the digest are the most useful messages received, and every substantive note is read carefully.

The most actionable submissions specify three things: the page in question, the exact passage they address, and the supporting citation — a DOI or PubMed identifier wherever possible. That allows verification against the source directly.

**Editorial mailbox:** editors@peptideresearchprotocols.com

## What this desk cannot do

So that correspondence is not left unanswered for the wrong reason, several things fall outside what this site can address. Peptide Research Protocols is a literature digest, not a clinic or a vendor, so the desk cannot:

- Advise on, recommend or comment on human use of any peptide discussed here.
- Suggest a dose, schedule or route of administration for any individual.
- Diagnose a condition or assess whether a published research finding applies to a particular person.
- Sell, source, recommend or help locate any compound from any supplier.
- Advise athletes subject to anti-doping rules on the use of these compounds — all three are WADA-prohibited, and several prohibitions are in- and out-of-competition.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.

---

Peer-reviewed literature on GH axis peptides, summarised without dosing guidance, clinical claims, or products.